Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: Results from FORTUNE-1, a prospective, multicentre randomised study
Annals of Rheumatic Diseases Nov 10, 2017
Yamanaka H, et al. - This study entailed the comparison between 3 preventive strategies for reducing gout flares during the initial introduction of urate-lowering therapy in patients with gout: stepwise dose increase of febuxostat, fixed-dose febuxostat + colchicine, and fixed-dose febuxostat. Findings demonstrated a greater efficacy of stepwise dose increase of febuxostat and low-dose colchicine prophylaxis in attenuating gout flares in comparison with fixed-dose febuxostat alone. It was observed that stepwise dose increase of febuxostat may be an effective alternative to low-dose colchicine prophylaxis during the introduction of urate-lowering therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries